NF45/NF90-mediated rDNA transcription provides a novel target for immunosuppressant development.
Tsai HI, Zeng X, Liu L, Xin S, Wu Y, Xu Z, Zhang H, Liu G, Bi Z, Su D, Yang M, Tao Y, Wang C, Zhao J, Eriksson JE, Deng W, Cheng F, Chen H.
Tsai HI, et al. Among authors: chen h.
EMBO Mol Med. 2021 Mar 5;13(3):e12834. doi: 10.15252/emmm.202012834. Epub 2021 Feb 8.
EMBO Mol Med. 2021.
PMID: 33555115
Free PMC article.